NEW DELHI: Indian Pharmaceutical company Cipla has offered to manufacture an antiviral drug for bird flu called Zanamivir (Relenza) that is currently being manufactured by Glaxo Smithkline.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback